Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 21849674)

1.

Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46.

Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, Stolovich-Rain M, Nir T, Achdout H, Glaser B, Shapiro J, Naparstek Y, Porgador A, Dor Y, Mandelboim O.

J Immunol. 2011 Sep 15;187(6):3096-103. doi: 10.4049/jimmunol.1101269. Epub 2011 Aug 17.

2.

The activating receptor NKp46 is essential for the development of type 1 diabetes.

Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O.

Nat Immunol. 2010 Feb;11(2):121-8. doi: 10.1038/ni.1834. Epub 2009 Dec 20.

PMID:
20023661
3.

Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.

Glasner A, Ghadially H, Gur C, Stanietsky N, Tsukerman P, Enk J, Mandelboim O.

J Immunol. 2012 Mar 15;188(6):2509-15. doi: 10.4049/jimmunol.1102461. Epub 2012 Feb 3.

4.

Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.

Westgaard IH, Berg SF, Vaage JT, Wang LL, Yokoyama WM, Dissen E, Fossum S.

J Leukoc Biol. 2004 Dec;76(6):1200-6. Epub 2004 Sep 8.

5.

The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes.

Gur C, Enk J, Weitman E, Bachar E, Suissa Y, Cohen G, Schyr RB, Sabanay H, Horwitz E, Glaser B, Dor Y, Pribluda A, Hanna JH, Leibowitz G, Mandelboim O.

PLoS One. 2013 Aug 29;8(8):e74033. doi: 10.1371/journal.pone.0074033. eCollection 2013.

6.

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

Halfteck GG, Elboim M, Gur C, Achdout H, Ghadially H, Mandelboim O.

J Immunol. 2009 Feb 15;182(4):2221-30. doi: 10.4049/jimmunol.0801878.

7.

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.

Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L, Biassoni R, Moretta A.

J Exp Med. 1998 Sep 7;188(5):953-60.

8.

Dimerization of NKp46 receptor is essential for NKp46-mediated lysis: characterization of the dimerization site by epitope mapping.

Jaron-Mendelson M, Yossef R, Appel MY, Zilka A, Hadad U, Afergan F, Rosental B, Engel S, Nedvetzki S, Braiman A, Porgador A.

J Immunol. 2012 Jun 15;188(12):6165-74. doi: 10.4049/jimmunol.1102496. Epub 2012 May 21.

9.

The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.

Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP.

J Immunol. 2009 Nov 15;183(10):6579-87. doi: 10.4049/jimmunol.0901935. Epub 2009 Oct 21.

10.

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, López-Botet M.

Blood. 2011 Jan 20;117(3):848-56. doi: 10.1182/blood-2010-08-301374. Epub 2010 Oct 28.

11.

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46.

Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A, Kedar E, Porgador A, Mandelboim O.

Blood. 2004 Jan 15;103(2):664-72. Epub 2003 Sep 22.

12.

Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.

Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.

J Leukoc Biol. 2005 Aug;78(2):359-71. Epub 2005 Jun 3.

14.

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.

Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A.

Nature. 2001 Feb 22;409(6823):1055-60.

PMID:
11234016
15.

The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity.

Biassoni R, Pessino A, Bottino C, Pende D, Moretta L, Moretta A.

Eur J Immunol. 1999 Mar;29(3):1014-20.

PMID:
10092106
16.
17.

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Walzer T, Bléry M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, André P, Gauthier L, Daniel L, Chemin K, Morel Y, Dalod M, Imbert J, Pierres M, Moretta A, Romagné F, Vivier E.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3384-9. Epub 2007 Feb 20.

18.

NKp46.

Mandelboim O, Porgador A.

Int J Biochem Cell Biol. 2001 Dec;33(12):1147-50. Review.

PMID:
11606250
19.

Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression.

Kim HR, Chwae YJ, Kim J.

Scand J Immunol. 2010 Jun;71(6):413-9. doi: 10.1111/j.1365-3083.2010.02395.x.

PMID:
20500693
20.

2B4 functions as a co-receptor in human NK cell activation.

Sivori S, Parolini S, Falco M, Marcenaro E, Biassoni R, Bottino C, Moretta L, Moretta A.

Eur J Immunol. 2000 Mar;30(3):787-93.

PMID:
10741393
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk